Johnson & Johnson shares fell Monday, extending the stock's plunge on the back of a Reuters investigation into the company's baby powder. The healthcare company was aware for decades that its baby powder contained traces of asbestos, according to Reuters, citing internal documents. Johnson & Johnson has denied the report. The majority of Wall Street analysts viewed the stock's initial decline as an overreaction, but acknowledged headwinds could arise from investors' concerns about the...


Become a member to take advantage of more features, like commenting and voting.

Jobs to Watch